My Profile
Rolfe Winkler
Your guide to
the capital jungle
See all posts
Sat 28 Nov 2009 | 22:00 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. (VNDA.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
VNDA
on other exchanges
As of 27 Nov 2009
10.56
USD
Price Change
-0.03
Percent Change
-0.28%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Clark, William
40
2004
Senior Vice President, Chief Business Officer, Secretary
Polymeropoulos, Mihael
49
2005
President, Chief Executive Officer, Director
Dugan, Richard
67
2005
Director
Halak, Brian
37
2004
Director
Ramsay, David
45
2004
Director
Watkins, H. Thomas
56
2006
Director
Pien, Howard
51
2007
Director
Karabelas, Argeris
56
2003
Chairman of the Board
Feeney, John
54
2009
Acting Chief Medical Officer
Irish, Stephanie
38
2009
Acting Chief Financial Officer, Treasurer, Controller
Find out more about VNDA.O
Insider Trading